The Institute of Pharmaceutical Innovation

Resources

Jump to Resources Navigation

News

Tuesday 28th April, 2009 IPI launches fundraising campaign to make better HIV medicines for children

The IPI along with its global partners is committed to developing child friendly improved HIV medicines.

We are looking to raise funds from generous individuals in order to help our cause.

Donation Online button

To find out more about the project please click here

You can donate in a number of ways:

1) By cheque made out to
“University of Bradford – Project code DW44/10098”
Please post to Dr. Riddhi Shukla, Institute of Pharmaceutical Innovation, University of Bradford, Bradford, West Yorkshire, BD7 1DP, UK.
2) By bank transfer please quote Project code: DW44/10098
Bank Name:Lloyds TSB Bank PLc
Address:
Hustlergate Branch
45 Hustlergate
Bradford
BD1 1NT
West Yorkshire, UK
Bank Account Name: University of Bradford
Bank Account No: 04698283
Bank Account Code: 30-91-12
Iban No: GB61LOYD 3091 1204 6982 83
Swift Code: LOYDGB21016
3) By ringing Payzone with your debit/credit card details
+44 1274 233137
+44 1274 233138
Please quote Project code: DW44/10098

Thank you very much for your support

Further Details

Project purpose:- The project aims to address the distressing fact that children with HIV/AIDS are still dying unnecessarily because of a lack of affordable “child-friendly” anti-retroviral drugs at appropriate doses in age appropriate presentations.

Not all anti-retroviral drugs in current WHO guidelines for children are currently made, or are available, in formulations suitable, palatable, acceptable or feasible for use in paediatric populations.

Our solution will address the following issues currently faced by existing paediatric formulations:

*It will be palatable

*Provide a flexible dosing system that will be easy to administer

*Packaging can be adjusted to provide different dose combinations as required

*Require a once or twice daily administration

*Same dosing at both am and pm

*Provide control of therapeutic levels especially for narrow therapeutic window

*Stable product, shelf life 2-3 years

*Reduced storage/warehousing requirements

*Single manufacturing process
Can easily be distributed (due to compact nature) through mobile and semi-mobile HIV/AIDS health clinics in order to provide greater reach of treatment

If you are interested in finding out more about this project please contact:
Dr. Riddhi Shukla
+ 44 1274 236196

Resources Navigation (Back to Content)